MedTrace Logo

Exercise Pulmonary Transit Time

NCT04336995 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2024-04-09

Study results available
· View outcomes & findings →

Summary

The study seeks to measure pulmonary transit time via contrast-echocardiography before and after exercise.

Conditions

  • Heart Failure, Diastolic

Interventions

DIAGNOSTIC_TEST

contrast echocardiography

giving echocardiographic contrast and taking echocardiographic images before and after exercise

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Ken Monahan, MD · VUMC

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-27
Primary Completion
2021-08-25
Completion
2024-03-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04336995 on ClinicalTrials.gov